Evaluation of ciladopa hydrochloride as a potential anti-parkinson drug
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 25 (9) , 973-979
- https://doi.org/10.1016/0028-3908(86)90190-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Controversial Role of Bromocriptine in Parkinsonʼs DiseaseClinical Neuropharmacology, 1985
- The therapeutic potential of centrally acting dopamine agonistsTrends in Pharmacological Sciences, 1984
- Up and Down RegulationClinical Neuropharmacology, 1982
- The pharmacological evaluation of pergolide mesylate as a potential anti-Parkinson agentNeuropharmacology, 1980
- Effect of central injections of dopamine on core temperature and thermoregulatory behaviour in unrestrained ratsNeuropharmacology, 1979
- Considerations in the management of parkinsonismNeurology, 1978
- Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidolBrain Research, 1977
- Levodopa‐Induced dopamine receptor hypersensitivityAnnals of Neurology, 1977
- Amphetamine-Induced Dopaminergic Hypersensitivity in Guinea PigsArchives of General Psychiatry, 1975
- Mode of action of apomorphine and dexamphetamine on gnawing compulsion in ratsPsychopharmacology, 1967